GLP-1 drugs show promise for more than weight loss. They also cut substance abuse and are changing how we think about the ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

There is new evidence that drugs like Ozempic can reduce a person's risk of addiction. A large study found that people who started taking GLP-1 drugs for weight loss or diabetes were less likely to ...

Could Mounjaro or related drugs treat cannabis use disorder and other substance addictions? Maybe so. GLP-1 receptor agonists like Ozempic and Victoza were originally developed to treat type 2 ...

Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and genetic tools, scientists still cannot fully explain why some people get ...

Researchers at the University of California San Diego have completed a massive genetic study that identifies key biological ...

Lifestance Health reports that HBO's 'Euphoria' addresses addiction and grief, highlighting the complex realities of recovery ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) receptor ...

Although the coronavirus has overshadowed the drug crisis, fatalities due to opioids and stimulants continue to climb, with a new high of 81,000 deaths in the 12 months ending in May 2020. One remedy ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...